Life Sciences

Miach Orthopaedics in Westborough has secured $40 million in financing for its U.S. rollout of an implant to improve ACL tear recovery.

TheracosBio, a Marlborough-based drug manufacturer, received U.S. Food and Drug Administration approval for a new type 2 diabetes treatment.

As healthcare inequities remain a persistent and pressing issue, the identification of ways the healthcare system can make future-focused moves to address them is top-of-mind at Commonwealth Medicine.

Framingham clinical research firm Alira Health has promoted Annabel de Maria to the newly created role of chief patient officer, effective immediately.

Biostage, Inc. in Holliston has removed the interim designation from David Green’s title and made him biotechnology company’s CEO.

Venture Capital money continued to flow into Massachusetts’s biopharma sector in 2022.

French pharmaceutical company Seqens will unveil its new research and development center in Devens on January 31.

Framingham clinical research firm Alira Health, which is anticipating a spike in demand as more patients have control over their data, has raised $58 million in capital funding.

Hologic Inc., a Marlborough medical technology company, reported a 41.2% decrease in diagnostic testing revenue in the first quarter of fiscal 2023.

After previously leading its Marlborough operations, Maurice Phelan has returned to life sciences company Sartorius AG to...